Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Current Deferred Revenue (2023 - 2025)

Baird Medical Investment Holdings has reported Current Deferred Revenue over the past 3 years, most recently at $793412.0 for Q4 2025.

  • For Q4 2025, Current Deferred Revenue changed 0.17% year-over-year to $793412.0; the TTM value through Dec 2025 reached $793412.0, changed 0.17%, while the annual FY2025 figure was $793412.0, 0.17% changed from the prior year.
  • Current Deferred Revenue for Q4 2025 was $793412.0 at Baird Medical Investment Holdings, down from $1.1 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $1.1 million in Q2 2025 and troughed at $200000.0 in Q4 2023.
  • A 3-year average of $719737.0 and a median of $792757.0 in 2024 define the central range for Current Deferred Revenue.
  • Biggest five-year swings in Current Deferred Revenue: soared 296.05% in 2024 and later increased 0.17% in 2025.
  • Year by year, Current Deferred Revenue stood at $200000.0 in 2023, then soared by 296.05% to $792102.0 in 2024, then rose by 0.17% to $793412.0 in 2025.
  • Business Quant data shows Current Deferred Revenue for BDMD at $793412.0 in Q4 2025, $1.1 million in Q2 2025, and $792102.0 in Q4 2024.